TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/2/24 16:30 | 1/31/24 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Reilly Thomas Charles | NJ | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 45 | 187 | 69 | D | ||||||||||||||
1/12/24 17:27 | 1/10/24 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Reilly Thomas Charles | NJ | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 52 | 49 | D | |||||||||||||||
7/5/23 16:46 | 7/1/23 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Reilly Thomas Charles | NJ | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 17 | 191 | 25 | D | ||||||||||||||
6/22/23 17:10 | 6/20/23 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Reilly Thomas Charles | NJ | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 33 | 17 | D | |||||||||||||||
3/4/22 17:54 | 3/3/22 | CARA | Cara Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Reilly Thomas Charles | CT | O | CFO | S | -23 | 11.38 | 0 | -2 | -5 | 38 | D | ||||||||||||||
9/1/21 18:08 | 8/30/21 | CARA | Cara Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Reilly Thomas Charles | CT | O | CFO | S | -28 | 14.20 | 0 | -2 | -37 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |